Skip to content

Wednesday, October 28, 2026

Data from SEC filings, checked daily

Public filings, plainly told

About Method Sources Newsletter

Insider tradingForm 4

Immunovant, Inc. (IMVT) Insider Trading

8 open-market trades reported since Aug 21, 2026: 0 purchases worth $0 and 8 sales worth $735K.

By insider

Insider	Role	Buys	Bought	Sells	Sold	Latest
Jay S. Stout	CTO	0	$0	2	$197K	Oct 23, 2026
Melanie Gloria	COO	0	$0	2	$207K	Oct 9, 2026
Van Tuyl Christopher	General Counsel	0	$0	2	$146K	Oct 9, 2026
Eric Venker	CEO	0	$0	1	$120K	Oct 5, 2026
Atul Pande	Director	0	$0	1	$65K	Aug 28, 2026

All trades

IMVT insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	3 mo. after	Filing
Oct 23	Oct 21	Jay S. StoutCTO	CTO	▼ SELL	2,595	28.94	$75K	−1.3%		Form 4 ↗
Oct 9	Oct 7	Jay S. StoutCTO	CTO	▼ SELL	3,809	32.06	$122K	−1.9%		Form 4 ↗
Oct 9	Oct 7	Melanie GloriaCOO	COO	▼ SELL	2,241	32.06	$72K	−1.0%		Form 4 ↗
Oct 9	Oct 7	Van Tuyl ChristopherGeneral Counsel	General Counsel	▼ SELL	1,327	32.06	$43K	−0.8%		Form 4 ↗
Oct 5	Oct 2	Eric VenkerCEO	CEO	▼ SELL	3,506	34.11	$120K	−1.3%		Form 4 ↗
Sep 25	Sep 23	Van Tuyl ChristopherGeneral Counsel	General Counsel	▼ SELL	2,846	36.36	$103K	−1.6%		Form 4 ↗
Aug 28	Aug 28	Atul PandeDirector	Director	▼ SELL10b5-1	1,500	43.27	$65K	−1.3%		Form 4 ↗
Aug 21	Aug 20	Melanie GloriaCOO	COO	▼ SELL	3,056	44.16	$135K	−1.4%		Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings